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Abstract
Age-related macular degeneration is a debilitating condition that manifests as a loss of the
central portion of an individual’s field of vision, affecting 1 in 3 people over the age of 80. With
regards to the retina, the organ primarily responsible for an individual’s sense of vision, this
condition is associated with the degeneration of the central point in the retina, known as the
macula, which contains the highest concentration of light-sensitive photoreceptors. It is
currently known that the human retina exhibits a gradual decrease in protective detoxifying
factors such as glutathione-S-transferase-1 and catalase as well as increased lipid peroxidation,
all of which resulting in the age-related increase in autofluorescent lipofuscin between the
retina and the choroid. This prevents the proper deliverance of nutrients to the foundational
layer of cells in the retina, leading to oxidative stress-related apoptosis of first the retinal
pigmented epithelium (RPE) and then the photoreceptors.
MicroRNAs (miRNAs) are a group of endogenous noncoding RNA molecules that originate
from parts of the genome that were originally speculated to be “junk” DNA. However, it is now
known that these small RNA molecules are responsible for gene silencing on the posttranscriptional level via the degradation or transcription inhibition of specific mRNA transcripts.
In the context of age-related macular degeneration, certain miRNAs may be upregulated to
induce the downregulation of apoptotic genes. On the other hand, certain miRNAs is may
become downregulated to promote enhanced expression of protective factors. We hypothesize
that miRNAs play a role in regulating oxidative response of RPE cells, which may then
contribute to cell survival by the upregulation of endogenous pro-survival antioxidant elements.
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Introduction
Anatomy of the Retina
The vertebrate retina is a multilayered structure composed of multiple cell types, including
rod and cone photoreceptors, ganglion and amacrine cells, and retinal pigmented epithelium
cells (RPEs). These cells are arranged in layers at the back of the eye, forming a complex neural
network that allows for the sense of sight.[1] As shown in Figure 1, this multilayered structure
lines the back of the eye between a vascular layer, known as the choroid, and the vitreous gel.
The retina itself is known to be made up of two distinct regions. The neuroretina is composed
of various neural cell types such as the rod and cone photoreceptors, amacrine cells and
ganglion cells, all of which are collectively responsible for relaying signals generated by light
coming into the eye. In this process, light enters the eye through the lens and excites the lightsensitive photoreceptors. These cells then send signals via the amacrine cells to the retinal
ganglion cells, whose axons form the optic nerve by which these signals are sent to the brain.
The second region of the retina is known as the pigmented epithelium, which is a layer of
cells known as retinal pigmented epithelial cells (RPEs). This layer of cells plays multiple
important roles in maintaining the intercellular homeostasis of the neuroretina, including the
phagocytosis of outer segments shed by the photoreceptors,[2] maintaining the separation
between the neuroretina and the blood supply by the formation of tight junctions,[3] the
transfer of ions and other nutrients from the blood supply to the neuroretina,[4] and the
conversion and storage of retinoid as part of the visual transduction cycle.[5]
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Figure 1: Anatomy and Functional Schematic of the Vertebrate Retina. Modified from “How the Retina Works,”
American Scientist, (91) 2003. a. Anatomical diagram of the eye with emphasis on the retina and the cellular layers
it is composed of. b. Functional schematic of the retina.

Visual impairment can result from damage to the retina from various sources that one may
encounter during his or her lifespan. Age-related macular degeneration (AMD) is an example of
the lifelong progression in which the accumulation of damage to the retina can coalesce in the
loss of sight, which can be a problematic issue with regards to the quality of life in the aging
population. There are two types of cells currently under investigation in the context of agerelated retinal degeneration: the light sensitive rod and cone photoreceptors found in the
neuroretina and the RPE cells that form the foundation of the retina. Functionally, as previously
mentioned, the RPE cells provide structural and nutrient support for the photoreceptors.
Therefore, the pigmented epithelium plays a vital role in the viability of the retina, the
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degeneration of which would inevitably lead to the degeneration of downstream cells such as
the photoreceptors.[6]
Age-Related Macular Degeneration: Symptoms and Treatments
Age-related macular degeneration (AMD) is a prime example of a neurodegenerative
phenomenon, displaying an age-related progression of degeneration in the retina. AMD is the
leading cause of vision loss in people over the age of 50 years, affecting approximately 15
million people in the U.S. The condition is characterized by the deterioration of the macula, a
portion of the retina that contains the largest concentration of cone photoreceptor cells and is
responsible for high resolution vision. There are two main forms of AMD: dry and wet. Wet
AMD, the more rare form of AMD, is associated with the resulting retinal detachment due to
the formation of new blood vessels in the retina. Dry AMD, which accounts for over 90% of
AMD cases, is associated with the age-related build-up of cellular debris between Brusch’s
membrane and the RPE layer. This accumulation continues with age, leading to the atrophy and
eventual death of the pigmented epithelium, ultimately disrupting the cellular homeostasis of
downstream retinal cells and eventually cell death of cells in the neuroretina.[7] This
progression is outlined in Figure 2.
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Figure 2: Progression of Cell Death Exhibited in AMD. As cellular debris builds up between Brusch’s membrane
and the RPE layer, cells in the RPE layer eventually undergo cell death. As more RPE cells die due to cellular stress,
intercellular homeostasis in the neuroretina is disrupted, leading to the cell death of photoreceptors and other
neural cells.

Symptoms of AMD include the perceived distortion of straight lines, diminished or changed
color perception, and dark blurry areas or white-outs that appear at the center of vision. As a
result, individuals affected by AMD will present with “reversed tunnel-vision,” where they have
a blind spot at the center of their field of vision that grows outward with age, as described in
the simulation from the National Eye Institute in Figure 3. Eventually the blind spot will
gradually progress outward with age as more retinal cells succumb to the degenerative process.
In the more advanced form of this degeneration, affected individuals will develop the condition
known as geographic atrophy (GA), at which point the deterioration completely disrupts the
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layer of pigmented epithelial cells, leading to legal or complete blindness if a clinical
intervention isn’t administered.

Figure 3: Field of Vision Perceived by an Individual Affected by AMD Compared to an Unaffected Individual.
Compared to an individual unaffected by AMD, an AMD patient experiences a blind spot at the center of their field
of vision. With age, as retinal cell death accumulates due to increasing cellular stress, this blind spot grows
outward. Eventually, without intervention, this phenomenon will result in legal or complete blindness.

To date, there are no treatments that have been shown to effectively halt the
degeneration of the retina or rescue vision once cells in the retina have been lost. Therefore,
current aims in scientific research are focused on the prevention of this degeneration. With
regards to therapeutics, drugs used in the treatment of AMD are VEGF-inhibitors which attempt
to halt retinal degeneration through the neovascularization process associated with wet
AMD.[8] However, this has no use in the treatment of the dry form of AMD, which doesn’t
manifest through the neovascularization process. Additionally, VEGF-inhibitor treatments have
not been shown to completely rescue the vision of such an affected individual once retinal cells
are lost to the degenerative process. Therefore, current strategies that are under scientific
investigation include gene therapy and cell-replacement therapy. Although gene therapy has
5

been valued in the treatment of various conditions, the drawback in this case once again lies in
its use in late stage AMD. The data presented by Maguire et al. in 2009 shows that the best
visual improvements after the use of adeno-associated viruses to restore the functionality of
RPE65, a marker of cellular maturity in RPEs, has been seen only in children, whose
photoreceptors have not already been lost to the degeneration process.[9] Furthermore, gene
therapy is generally most useful in conditions where a loss-of-function mutation is observed or
enzyme replacement is necessary, both of which are not the case for AMD and thus have
limited therapeutic use for the prevention of retinal degeneration.
Current research endeavors regarding the treatment of AMD highlight the use of embryonic
stem cells and induced pluripotent stem cells to replace retinal cells that have been lost to the
degenerative process. Various groups focus on the inhibition of Wnt and BMP signaling
pathways along with the activation of IGF signaling in order to derive retinal cells from
pluripotent stem cells.[10-12] Additionally, differentiated retinal cells derived in such a manner
have been shown to exhibit integration and survival after transplantation, even providing a
rescue of sight in a Crx-deficient mouse model, albeit to a limited extent.[13-15] To date, nonmammalian vertebrates have been shown to have the remarkable ability to replace neurons
that have been lost by damaging events.[16-18] However, this phenomenon has yet to be seen
to any significant extent in humans. Therefore, despite advances in therapeutic treatments for
AMD by cell-replacement strategies, mechanistic studies promise to be invaluable clinical assets
in order to elucidate preventative strategies for the retinal degenerative process.
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Oxidative Stress as a Key Factor in the Progession of AMD
In light of the potential of understanding the mechanisms through which AMD progresses,
many investigators focus on defining factors that contribute to the degenerative nature of
AMD. From such information, strategies can be developed to help slow or prevent the
degenerative process. Current research speculates the beneficial effects of omega-3 fatty acids
and various antioxidant molecules in measures to prevent AMD, implicating the role of diet.[19]
In one such study, omega-3 fatty acids were shown to have beneficial effects on AMD-like
legions in DKOrd8 mice by anti-inflammatory mechanisms of docosahexaenoic acid and
eicosapentaenoic acid (EPA).[20] Other environmental factors that have been implicated in the
development of AMD include smoking and exposure to smoke, which have been shown to
cause systemic oxidative stress,[21, 22] as well as genome instability and DNA damaged caused
by exposure to blue and ultraviolet (UV) light.[23] Genetic factors have also been proposed to
play a role in the progression of AMD. It has been shown that mutation-induced dysfunctional
expression of complement factor H is strongly associated with AMD development through the
induction of chronic inflammation, leading to excessive cellular damage to retinal cells.[24, 25]
Because the underlying cause of AMD is complex and multifactorial, a single underlying factor
that drives the degenerative process is considerably difficult to define. This problem is
compounded due to the fact that most animal species lack a macula, therefore finding the
appropriate animal model system for in vivo studies is quite difficult.[26] Recent studies have
associated oxidative stress as a key element in the progression of AMD, presenting evidence of
a decreased expression in glutathione S-transferase-1, increased lipid peroxidation, and a
decreasing trend in catalase activity that continues with age.[27] As a result, there is an age7

related increase in autofluorescent lipofuscin between the RPE layer and Brusch’s membrane.
This substance contains a molecule known as A2E, a pyridinium bisretinoid byproduct of the
visual phototransduction pathway. Importantly, A2E is known to be a potent generator of
reactive oxygen species (ROS) in the RPE, the accumulation of which can lead to cell death.[28]
Therefore, understanding how the RPE reacts, and what pro-survival mechanisms are affected
in response to oxidative stress, has potential for further investigations into preventative
measures against AMD. One way to investigate cellular response to stress is by focusing on the
production of endogenous factors that can play a role in pro-survival mechanisms and how the
expression of such factors are affected by cell stress.
One of the most notable signaling pathways that have been associated with oxidative stress
response is the NRF2/KEAP1 pathway. This signaling pathway implements cellular responses to
oxidative stress through the production of antioxidant response elements (AREs).[29, 30] Under
basal conditions, KEAP1 is bound to NRF2, which then directs NRF2 into degradation in the
cytosol. However, as visually outlined in Figure 4, the accumulation of ROS in the event of
oxidative stress leads to the dissociation of KEAP1 from NRF2, stabilizing this factor. NRF2 is
then translocated into the nucleus where it induces the expression of AREs such as NAD(P)H
dehydrogenase quinone 1 (NQO1), heme oxygenase 1 (HMOX1), as well as the catalytic and
regulatory subunits of glutamate-cysteine ligase (GCLC and GCLM respectively).
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Figure 4: NRF2/KEAP1 Signaling Pathway.

Basic Biology of miRNAs
Various studies highlight the role of small, noncoding RNA molecules known as microRNAs
(miRNAs) in the progression of various human disease conditions.[31] These 22-25 nucleotide
small RNA molecules silence gene expression via the degradation or translational inhibition of
target mRNA molecules. Such molecules had escaped the notice of many researchers until
1993, when Victor Ambros, Rosalind Lee, and Rhonda Feinbaum discovered that lin-4, a gene
known to play a significant time-dependent role in C. elegans larval development, does not
encode a protein. In fact, when expressed, the gene produces a pair of small RNA molecules
that have been suggested by the group to inhibit lin-14 expression by RNA-RNA antisense
interactions.[32]
9

Figure 5: miRNA Biogenesis Pathway. Complete processing of miRNA transcripts leads to the loading of the
mature miRNA molecule onto the RNA-induced silencing complex, which targets specific messenger RNA
sequences for gene silencing.

As outlined in Figure 5, the production of mature miRNAs follows a distinctly different
pathway from that of functional messenger RNAs. miRNA genes are transcribed by RNA
polymerase II to produce a primary miRNA (pri-miRNA) transcript, which is then processed by a
microcompressor complex comprised of two factors, DROSHA1 and DGCR8, to produce the premiRNA transcript. This product is exported out of the nucleus by Exportin 5 and then processed
by DICER1 to form a miRNA duplex composed of 5p and a 3p strands. This duplex dissociates
and the mature 5p component is loaded onto the RNA-Induced silencing complex to form the
miRNA-RISC, which then binds to the 3’ untranslated region (3’UTR) of specific mRNA
transcripts.
10

With regards to function, an individual miRNA molecule is as important to gene expression as
an individual transcription factor, in this case to regulate the expression of multiple target
genes at the post-transcriptional level.[33] After a mature miRNA transcript is loaded onto the
RISC, the miRNA-RISC can target specific messenger RNA (mRNA) transcripts for gene silencing
depending on the extent of complementary binding. Complete complementarity effectively
leads to the degradation of the mRNA molecule by the RISC. Partial complementarity between
an miRNA-RISC and an mRNA transcript doesn’t degrade the mRNA molecule, however it does
prevent its translation into a functional protein. Therefore, any binding of an miRNA-RISC to an
mRNA molecule effectively leads to gene silencing at the post-transcriptional level. It is
speculated that miRNAs may be involved in the regulation of all major cellular functions in the
cell, including differentiation, replication, mobility, and apoptosis through the inhibition of key
mRNA gene targets. Therefore, such molecules present much potential in the study of
development, physiology, and disease in humans.

MicroRNAs in RPE Cells
With regards to the context of retinal cells, past studies highlight the expression and
inhibition of miRNAs such as miR204, miR302,[34] miR184, miR187, and miR211[35] in the
maintenance of RPEs. For example, it has been reported that the continuous expression of
miR204 and the continuous inhibition of miR302 contributes to the expression of markers such
as ZO-1, RPE65, MERTK, and MiTF through the specific targeting of CTNNBIP1, a reported
inhibitor of Wnt signaling, and TGFBR2, a factor that aids in the direction of the mesodermal
and endodermal cell fates, respectively.[34] Of particular note, it has been shown that miRNAs
11

play a role in RPE cell viability in the pathogenesis of AMD through the dysregulation of
protective miRNAs[31] or the accumulation of ALU RNA elements. In both instances, the
disease progression has been suggested to be driven by the loss of DICER1, a key protein
involved in miRNA biogenesis.[36] Additionally, recent studies have observed shifts in miRNA
expression profiles when comparing human ARPE-19 cells that have undergone H2O2-induced
oxidative stress or treatment with the antioxidant curcumin.[37] Although this study involved
only acute treatments of H2O2 rather than chronic treatments, which would be a more
appropriate experimental design to study AMD with, this indeed suggests the presence of
miRNA-dependent pro-apoptotic and anti-apoptotic mechanisms in RPE cells that are activated
in response to stress signaling.

Research Focus
As described previously, miRNAs are thought to play a role in how cells react to stress and
disease conditions. Data from immortalized cell lines such as ARPE-19 may not accurately and
comprehensively represent the disease due to the highly proliferative nature of the cell line’s
biology. Therefore, RPEs derived from human embryonic stem cells (hESCs) appear to be the
ideal candidate for studies on the miRNA profiles of the AMD disease phenotype. Although
there have been investigations into miRNA and gene profiling of short-term stress phenotypes,
there has yet to be a comprehensive study looking into such profiling associated with long-term
stress with a gradually increasing concentration of stressor, which would be a more appropriate
model of AMD. This would be more adequately reflective of the accumulation of lipofuscin
products under the RPE layer. Based on previously published methods of deriving retinal cell
12

types from hESCs, including the RPE cell fate[11] our lab seeked to develop a model system
displaying the chronically stressed phenotype associated with AMD through paraquat-induced
chronic oxidative stress.[38] Once a model system has been developed, changes in miRNA
expression can then be monitored by quantitative PCR analysis with modifications designed for
the analysis of mature miRNA molecules.[39] This information can then be cross-referenced to
the expression profile of protective antioxidant factors such as those found in the NRF2/KEAP1
pathway.

Materials and Methods
Cell Culture and RPE Determination Conditions
Undifferentiated embryonic stem cells or induced pluripotent stem cells derived from a
patient with Leber’s congenital amaurosis were maintained in Essential 8 basal medium (Gibco)
supplemented with 1% Essential 8 supplement (Gibco) and 1% Pen/Strep Amphotericin B
(Lonza) on culture vessels coated with Matrigel (BD Biosciences). The media of these cells were
changed every day and grown in a 37o C incubator with 5% CO2 and 5% O2 before
differentiation. Differentiated RPE cells were maintained in MEM/EBSS with 2.00 mM LGlutamine and Earle’s balanced salts (Hyclone) supplemented with Knockout tm serum
replacement (Gibco), 1% for maintenance of mature RPEs and 5% for the proliferation of RPEs
to confluency before maturation, 1% Pen/Strep Amphotericin B (Lonza), 1% Glutamaxtm
(Gibco), 125 mg taurine, 10 µg hydrocortisone, 6.5 ng triiodo-thyronin, and 0.1% plasmocin
prophylactic (InvivoGen). The media of RPE cells was changed every other day, grown and
maintained in a 37o C incubator with 5% CO2.
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For the differentiation of embryonic stem cells into the RPE fate, undifferentiated cells were
subjected to a 3 week of treatment with 10 ng/mL DKK1 (R&D Systems), noggin (R&D Systems),
and IGF1 (R&D Systems) in DMEM/F-12 1:1 with 2.50 mM L-Glutamine and 15 mM HEPES
(HyClone), 1% sodium pyruvate (Corning), 1% N-2 supplement (Gibco), 1% HEPES (HyClone), 1%
Pen/Strep Amphotericin B (Lonza), and 0.1% plasmocin prophylactic (InvivoGen).
Spontaneously appearing pigmented foci were picked and transferred to a separate culture
vessel coated with Matrigel for expansion and complete formation of traditional cobblestonelike morphology.

Stress Treatment of RPEs
Once hESC-derived RPEs have grown to 100% confluency, cells were subjected to treatment
with either paraquat (PQ), alternatively known as methyl viologen (Acros Organics), and
hydroquinone (Acros Organics) in order to induce either a low stress or chronic high stress
phenotype. To induce a low stress phenotype, RPE cells were treated with either stressor. The
cells were treated with either 20 µM of paraquat or 50 µM of hydroquinone over 9 days and
followed by 40 µM of paraquat or 100 µM of hydroquinone subsequently over 7-10 days.
To induce a high stress phenotype, RPE cells were treated in a similar manner. Paraquat
treatment involved 40 µM of paraquat over 9 days then 80 µM over the following 6 days, and
finally 160 µM over 5 days. In a similar fashion, hydroquinone treatment involved 100 µM over
9 days, 200 µM over the next 7 days, and 400 µM over 1 day. After each series of treatments,
RNA was extracted for miRNA analysis by real-time quantitative PCR.
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RNA Extraction, Reverse Transcription, and PCR Analysis
Total RNA was extracted from RPE cells using the Direct-zol RNA MiniPrep kit (Zymo
Research) according to the manufacturer’s recommended instructions. RNA samples were then
quantified by a NanoDrop 2000 apparatus (Thermo Scientific). cDNA was synthesized from 0.51 µg of total RNA template using the iScript cDNA Synthesis kit (Bio-Rad), the protocol of which
was modified to accommodate 400 nM of a reverse transcription stem-loop primer. Up to 5
reverse transcription stem-loop primers were used per reaction. Reactions occurred in a T100
Thermal Cycler (Bio-Rad) according to the manufacturer’s recommended instructions with the
addition of stem-loop oligonucleotide primers for mature miRNA transcripts.
Real-Time Quantitative PCR analysis was performed using a Bio-Rad CFX Connect Real-Time
PCR Detection System. Acquisition of data was then performed on a Bio-Rad CFX Manaer
software. Each 20 uL reaction was done in triplicate, each replicate comprising of a miRNAspecific forward primer, which binds to a miRNA of interest, and a universal reverse primer that
binds to the stem-loop structure created by the reverse transcription stem-loop primer. Both
primers were used at a final concentration of 400 nM with 1 µL cDNA diluted five-fold, 7.4 µL of
DEPC-treated water, and 10 µL of iTaq Universal SYBR Green Supermix (Bio-Rad). Sample data
values from quantitative PCR analysis were normalized to U6 small nuclear RNA-2 (RNU6-2).
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Target
miRNA

Mature Sequence

Forward Primer

Reverse Transcription Stem-loop Primer

200a

CAUCUUACCGGACAGU

GCGGCCATCTTACCGGACA

GCTACTTAGCGCGCTACTTACTGGACACTGGCAGTCGCGAGTGCTGGA

27b

AGAGCUUAGCUGAUUG
GUGAAC

GGCGCAGAGCTTAGCTGAT

GCTACTTAGCGCGCTACTTACTGGACACTGGCAGTCGCGATGGTGAAC

21

UAGCUUAUCAGACUGA
UGUUGA
GCUGGUUUCAUAUGGU
GGUUUAGA
UAGCACCAUCUGAAAUC
GGUUA
UAAGUGCUUCCAUGUU
UCAGUGG
CAUUAUUACUUUUGGU
ACGCG

GGCGCGTAGCTTATCAGACT

GCTACTTAGCGCGCTACTTACTGGACACTGGCAGTCGCGAGATGTTGA

GGCGGCTGGTTTCATATGG

GCTACTTAGCGCGCTACTTACTGGACACTGGCAGTCGCGAGGTTTAGA

GCGGGTAGCACCATCTGAA

GCTACTTAGCGCGCTACTTACTGGACACTGGCAGTCGCGAATCGGTTA

GGCGCTAAGTGCTTCCATGT

GCTACTTAGCGCGCTACTTACTGGACACTGGCAGTCGCGATTCAGTGG

GGCCGGCGCATTATTACTTT

GCTACTTAGCGCGCTACTTACTGGACACTGGCAGTCGCGAggtacgcg
GGTACGCG

UGAGAACUGAAUUCCA
UGGGUU
GGAUAUCAUCAUAUAC
UGUAAG
GGGGUUCCUGGGGAUG
GGAUUU
UCUGGCUCCGUGUCUU
CACUCCC
AGGGCUUAGCUGCUUG
UGAGCA
UAAAGUGCUUAUAGUG
CAGGUAG
AGGUUGGGAUCGGUUG
CAAUGCU

GGCGCGTGAGAACTGAATTC

GCTACTTAGCGCGCTACTTACTGGACACTGGCAGTCGCGACATGGGTT

GCGGGCGGATATCATCATAT

GCTACTTAGCGCGCTACTTACTGGACACTGGCAGTCGCGAACTGTAAG

GCGGGGGTTCCTGGGGA

GCTACTTAGCGCGCTACTTACTGGACACTGGCAGTCGCGATGGGATTT

GGCTCTGGCTCCGTGTCT

GCTACTTAGCGCGCTACTTACTGGACACTGGCAGTCGCGATCACTCCC

GGCGAGGGCTTAGCTGCT

GCTACTTAGCGCGCTACTTACTGGACACTGGCAGTCGCGATGTGAGCA

GGCCGCTAAAGTGCTTATAG

GCTACTTAGCGCGCTACTTACTGGACACTGGCAGTCGCGAGCAGGTAG

GGCGAGGTTGGGATCGGTT

GCTACTTAGCGCGCTACTTACTGGACACTGGCAGTCGCGAGCAATGCT

29b1
29a
302c
126

146a
144
23a
149
27a
20a
92a

Primer

Sequence

Universal Reverse Primer

GCGCTACTTACTGGACACTG

Table 1: List of Primers Used for qPCR Analysis of mature miRNA transcripts.
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Gene Target

Forward Primer

Reverse Primer

RNU6-2

TGGAACGATACAGAGAAGATTAG

TGGAACGCTTCACGAATT

GCLC

AAGTGGATGTGGACACCAG

CTGTCATTAGTTCTCCAGATGC

GCLM

GTTGACATGGCCTGTTCAG

AACTCCATCTTCAATAGGAGGT

HMOX1

AACTCCCTGGAGATGACTC

CTCAAAGAGCTGGATGTTGAG

NQO1

ACATCACAGGTAAACTGAAGG

ACATCACAGGTAAACTGAAGG

P21

GACACCACTGGAGGGTGACT

CAGGTCCACATGGTCTTCCT

Table 2: List of Primers Used for qPCR Analysis of Gene Targets.

Dichlorofluorescein Assay for ROS generation
To screen for ROS generation at a given time, 2’,7’-dichlorofluorescein 3’,6’-diacetate (Acros
Organics) diluted in DMSO to make a 10 mM stock solution was diluted to 5 µM with 1x Hank’s
Balanced Salt Solution (Cellgro). RPE cells were then incubated in this solution for 30 minutes
before images were taken under fluorescent microscopy.

Lentiviral Transduction of RPE cells for Manipulation of miRNA Expression
miRNA decoy expression plasmids used in this study were purchased from the Addgene
plasmid depository, including miR27b decoy (Addgene plasmid# 46603) and miR29b decoy
(Addgene plasmid# 46605)[40] expression plasmids. The miRNA expression plasmid used for
the overexpression of miR144-5p was purchased from Genecopoeia (HmiR0275-MR03). Data
obtained from the use of this plasmid was referenced to the use of a non-silencing, scrambled
miRNA expression plasmid that was also purchased from Genecopoeia (CmiR0001-MR03-B).
17

HEK293T cells were plated in 10-cm dishes and allowed to grow to ~70% confluency. 4 µg of
miR decoy expression plasmid was incubated with 2 µg pMD2 VSVG and 2µg of psPAX2
lentiviral packaging plasmids in 750 µL of Cellgro Complete serum-free/low protein medium, 1X
(Corning). 45 µL of TransIT-LT1 (Mirus Bio) also incubated with 750 µL of Celgro Complete
medium. The two components incubated for 5 minutes at room temperature and then
incubated together for 15 minutes. The mixture was then added directly onto the cells. The
cells incubated at 37o C with 5% CO2 for 16 hours at which point, the lentivirus-containing
media was collected and replaced with Cellgro Complete medium with 1% FBS. Lentiviruscontaining media was then collected every 12 hours for up to 48 hours post-transfection.
Before transduction of RPE cells, lentivirus-media was filtered through a 0.45µm vacuum-driven
filter.
Once filtered, virus-containing media supplemented with polybrene (at a final concentration
of 4 µg/mL) was incubated with RPE cells over the course of 2 weeks, with media changes after
every 2 days.
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Results and Discussion
Establishment of Oxidative Stress Phenotype Reflective of AMD

Figure 6: Establishment of the AMD phenotype by the induction of oxidative stress in hESC-derived RPE cells a.
Undifferentiated hESC colonies in feeder-free condition. b. hESC-derived RPE cells displaying typical cobblestonelike morphology without stressor treatment. c. hESC-derived RPE cells subjected to 1 week of treatment with
hydroquinone. d. hESC-derived RPE cells subjected to an additional week of oxidant treatment, with 200 uM of
hydroquinone. e. hESC-derived RPE cells subjected to 1 week of treatment with paraquat. f. hESC-derived RPE cells
subjected to an additional week of paraquat treatment at a 160 uM concentration.

We began this study by the derivation of RPE cells from undifferentiated embryonic stem
cells or iPSCs derived from patients affected with Leber’s congenital amaurosis, as seen in
Figure 6a. These cells were then subjected to treatment with DKK1, noggin, and IGF according
to published protocols[11]. After 2-3 weeks of treatment with these factors, clusters of cells
exhibiting a cobblestone-like epithelial morphology were manually extracted and transferred
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into separate culture vessels for proliferation and maturation, resulting in a monolayer of
pigmented cells with a uniform morphology, as seen in Figure 6b.
We then conducted experiments to identify sublethal concentrations of hydroquinone and
paraquat for the treatment of hESC-RPEs, which would allow us to induce an oxidatively
stressed state with RPE cells without the activation of cellular pathways associated with
programmed cell death. This will allow us to identify pro-survival molecular pathways involved
in the cellular response to stress by PCR under high and low oxidative stress conditions. As
noted previously, we also aimed to develop a protocol of oxidative stress induction based on
the idea of a gradually accumulating stressor.
With the use of hydroquinone to induce a low stress phenotype, we found that the RPE cells
were able to stay alive at 50 µM of hydroquinone for 9 days, seen in Figure 6c at the 1-week
time point, and then 100 µM over the next 7 days. In order to induce a high, chronic stress
phenotype, we found we were able to use 100 µM of hydroquinone over 9 days, 200 µM over
the next 7 days, and then 400 µM over the following day.
In terms of the using paraquat to induce a low stress phenotype, we found that RPE cells
were able to stay alive at 20 µM paraquat over 9 days, which is seen in Figure 6e at the 1-week
time point, and then at 40 µM over the following 10 days. To induce a high, chronic stress
phenotype with paraquat, we were able to use 40 µM of paraquat over 9 days, 80 µM over the
next 6 days, and then 160 µM over the following 5 days. Upon further increase in concentration
of either hydroquinone or paraquat or time of stressor treatment, RPE cells have often been
seen to undergo apoptosis.
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With the use of both paraquat and hydroquinone, we were able to observe a change in the
traditional cobblestone-like morphology of RPE cells. Although this is less pronounced in the
use of paraquat, we have noted that these cells take on a more elongated morphology
reminiscent of fibroblasts, which we believe indicates an extent of an epithelial-tomesenchymal transition which is reflective of the proliferative characteristics of RPE cells. We
were able to then validate the generation of ROS associated with the incubation with oxidant
stressor by DCF staining of intracellular ROS, as seen in Figure 7.

Figure 7: Assessment of ROS Generation Associated with the use of Paraquat by DCF Assay. a. Untreated hESCRPE cells incubated with DCF, resulting in little to no fluorescence. b. hESC-RPE cells treated with paraquat at 160
µM (PQ160) after increasing concentrations of stressor, resulting in higher fluorescence intensity as seen in the
quantification in c. by Image J software.
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Correlation of Oxidative Stress Phenotype with NRF2/KEAP1 Activity and miRNA Analysis

Figure 8: Gene Analysis of Products of NRF2/KEAP1 Pathway Generated by Stress Signaling Gene expression
analysis of RPE cells subjected to chronic oxidative stress by hydroquinone up to a. 400 µM of hydroquinone
(HQ400) and b. 160 µM paraquat (PQ160). c. Unaffected RPEs compared to d. RPEs after 1 week treatment of 160
µM paraquat, both stained for NRF2.

Once an observable phenotype was seen in cells treated with oxidative stressors, we sought a
means to measure this phenotype through the analysis of pro-survival mechanisms. We elected
to check for the activity of the NRF2/KEAP1 pathway, a pathway known to play a significant role
in the production of endogenous antioxidant response elements (AREs) in lieu of stress
signaling. As seen in Figure 8a and 8b, both paraquat and hydroquinone were able to induce the
production of downstream products of the NRF2/KEAP1 pathway, including GCLC, GCLM,
HMOX1, and NQO1 by at least a 4-fold increase compared to untreated RPE control cells.
Interestingly, we also found that P21, a factor associated with cell cycle arrest and anti22

proliferative conditions[41] is also upregulated with stressor treatment. Additionally, p21 has
been shown to stabilize NRF2 by competitive binding, preventing KEAP1 from binding to NRF2.
This ultimately prevents the KEAP1-induced ubiquitination of NRF2 and therefore promotes a
pro-survival oxidative stress response.[42] We have also been able to confirm the translocation
of NRF2 into the nucleus and therefore the induction of endogenous antioxidant element
expression by immunostaining, as seen Figure 8c and 8d.
Next, we looked for potential miRNA candidates that may exhibit significant change in
expression due to oxidative stress signaling. Through various publications, we found a number
of potential miRNA candidates that may play a role in oxidative stress signaling as well as cancer
pathology. This list of miRNAs include miR200a[43], miR27b[44], miR23b[45], miR146a[46],
miR29a[47], miR29b[48], miR143[49], miR144[50]. As seen in Figure 9a and 9b, various miRNAs
such as miR27b, miR29b1, miR302c, miR126, and miR146a are upregulated by at least a 4-fold
difference with a lower concentration of paraquat, and miR200a, miR27b, miR23a, miR144,
miR149, and miR27a are upregulated by a similar amount. Both profiles suggest a negative
regulatory effect on gene mRNA transcripts, which may in fact play a role in the survival of RPEs
in light of an oxidant stressor. As seen in Figure 9c and 9d, various miRNAs such as miR20a,
miR29b1, miR29a, miR302c, and miR146a are upregulated under chronic oxidative stress
conditions with a higher concentration of hydroquinone. Interestingly, there are increases in
the expression of miR146a and miR29a under chronic oxidative stress conditions with a higher
concentration of paraquat, along with a rather striking decrease in miR144. This suggests a
dramatic upregulation in the gene targets associated with miR144-target UTR binding.
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Figure 9: Changes in miRNA expression profile associated with the oxidative stress phenotype a. and b. miRNA
expression profile of RPE cells subjected to low experimental oxidative stress with paraquat and hydroquinone.
miRNA analysis was performed on RPEs treated with up to 40 µM of paraquat (PQ40) and 100 µM of hydroquinone
(HQ100) with increasing concentrations of stressor as previously noted. c. and d. miRNA expression profile of RPE
cells subjected to experimental chronic oxidative stress with paraquat and hydroquinone. miRNA analysis was
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performed on RPEs treated with up to 400 µM of hydroquinone (HQ400) and 160 µM of paraquat (PQ160) with
increasing concentrations of stressor as previously noted.

Low Stress

High Stress

Both

Up: miR126, miR149, miR23a, miR126

Down: miR144

Up: miR29b1, miR29a, miR302c,

Up: miR20a

miR146a, miR27b,
miR144, miR27b up in low stress, down
in high stress

Table 3: Changes in miRNA Expression Associated with High and/or Low Oxidative Stress conditions

Modulation of miRNAs Associated with Oxidative Stress and its Effect on Stress Phenotype
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Figure 10: Analysis of Oxidative Stress in Light of miRNA inhibition. a. Untreated hESC-RPEs. b. RPE cells treated
with 320 µM of paraquat for 5 days. c. RPE cells expressing miR27b decoy treated with 320 µM of paraquat for 5
days. d. RPE cells expressing miR29b decoy treated with 320 µM of paraquat for 5 days. e. and f. miR27b and
miR29b decoy RPEs (respectively) expressing GFP under fluorescent microscopy. g. Quantitative real-time PCR
analysis of NRF2/KEAP1 pathway products expressed by mir27b and miR29b decoy-expressing RPEs after 5-day
treatment with 320 µM of paraquat. h. Quantitative real-time PCR analysis of pathology-associated miRNAs
expressed by miR27b and miR29b decoy-expressing RPEs after 5-day treatment with 320 µM of paraquat.

Based on the data described above, we next sought to directly assess the effects of the
manipulation of miRNA expression on the induction of an oxidative stress phenotype and RPE
survival. With regards to inhibiting miRNA expression, we specifically focused on two miRNAs,
miR27b and miR29b using a lentivirus-mediated expression method to express miRNA decoy
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constructs. As seen in Figure 10a-10f, despite robust expression of miR27b and miR29b decoys,
there is no clear increase in RPE death over the course of a 5-day treatment with 320 µM of
paraquat. Although a mild disruption of the uniform, cobblestone-like morphology could be
seen with paraquat treatment, the expression of the miRNA decoys didn’t induce any
morphology significantly different from that induced by paraquat treatment alone. Interestingly
however, quantitative real-time PCR analysis showed an upregulation of HMOX1 by up to a 2fold difference in RPEs expressing a miRNA decoy compared to unaffected RPEs treated with
paraquat, as seen in Figure 10g. Even more intriguingly, it seems that the inhibition of miR29b
and miR27b expression caused the inhibition of various other miRNAs such as miR205, miR28,
miR146, miR200a, miR27a, and miR29a. This suggests either a global inhibition of the miRNA
biogenesis pathway or potentially a cross-talk between the various oxidative stress response
miRNAs and antioxidant response element genes. The decoys, through the activation of a
negative regulator of other miRNAs, may have resulted in the inhibition of stress-associated
miRNAs. Additionally, this suggests the striking upregulation of various other factors that may
affect cell viability and functionality through the inhibition of miR27b or miR29b by miRNA
decoy activity.
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Figure 11: Analysis of Oxidative Stress in Light of miR144 Overexpression. a. Quantitative real-time PCR analysis
of antioxidant response element expression after 1 week of treatment with 320 µM paraquat (PQ320) under
conditions with elevated expression of miR144, compared to treated hESC-RPEs expressing a non-silencing
scrambled miRNA construct. b. miRNA analysis of the samples described in a.

Because of the marked decrease in miR144 expression in high stress conditions, we also
sought to asses the effects of miR144 overexpression on the oxidative stress response
implemented by RPEs in high stress conditions. To address this question, we induced the
elevated expression of miR144 as well as a scrambled, non-silencing miRNA construct in a
separate culture, both via lentivirus-mediated expression in hESC-RPEs. As seen in Figure 11a,
when compared to hESC-RPEs expressing a non-silencing miRNA construct, cells expressing
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heightened levels of miR144 displayed slightly elevated expression of antioxidant response
elements when treated with 320 µM paraquat for 1 week, particularly of HMOX1 and NQO1 by
approximately a 0.5-fold change. However, with regards to miRNA expression, the elevated
expression of miR144 with a similar stress treatment has been seen to induce the elevation of
miR27a and miR29a, which further points to the hypothesis that the expression of miRNAs
involved in a similar cellular function are affected by a change in the expression of one of the
miRNAs involved. In this case, a pro-survival change in miRNA expression induced the elevated
expression of miRNA27a and miRNA29a both of which have been shown to play a role in stress
conditions.

Conclusion
The etiology of AMD is one with an exceptionally complex nature. It is one that researchers
find difficult to define due to a lack of a good model system when the limitations presented by
immortalized cell lines and animal models are taken into consideration. In this study, we have
generated an in vitro disease model using human embryonic stem cell-derived RPE cells that we
believe reflects the nature of age-related macular degeneration using a protocol that allows us
to observe the oxidative stress phenotype using time-dependent increases in stressor
concentration. Using this model, we have been able to observe changes in miRNA expression of
miRNAs such as miR144, miR29b1, miR29a, miR27b, and miR23a, which have previously been
implicated in cancerous conditions. Additionally, these microRNAs exhibit changes in expression
between low, short-term stress and high chronic stress, suggesting miRNA-based mechanisms
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for immediate and long-term stress response for the purpose of maintaining cellular
homeostasis, as outlined in the heatmaps presented in Figure 12.

Figure 12: Differential Expression Between Low, Short-Term Stress (HQ100 and PQ40) and High, Chronic Stress
(HQ400 and PQ160) with the Use of Paraquat and Hydroquinone.

We have also been able to correlate these findings with enhanced expression of products
found in the NRF2/KEAP1 pathway. Interestingly, previously published publications indicate the
anti-cancer role of NRF2/KEAP1 activity through cytoprotection against oxidant damage.[50]
This, when taken into account the heightened expression of miRNAs such as miR29a and
miR29b1, which have been speculated to have DNA-demethylating and anti-tumor
capacities[48, 50], may indicate an anti-proliferative, antioxidant-associated mechanism used as
a defense against cell death. However, further studies involving the expression of gene
transcripts associated with cancer will have to be performed in order to further elucidate a
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causal mechanism of action for such miRNAs which may play a role in pro-survival conditions in
light of oxidative stress.
Of additional note, we have been able to make a preliminary observation of the effects of
stress-related miRNA inhibition by the inhibition of miR27b and miR29b through the use of a
decoy construct. We have also been able to note the effects of elevated stress-associated
miRNA expression through the overexpression of miR144, which led to the increase in the
expression of miR27a and miR29a, additional miRNAs implicated in RPE stress response. These
observations suggest a mechanism of inter-miRNA communication as seen in current
research,[50] where the inhibition of one miRNA affects the expression of various other related
miRNAs which may play a role in biological mechanisms such as redox homeostasis. Further
investigation will have to be performed in order to determine the role of factors that promote
the repression of such miRNAs and then elucidate a mechanism portraying a regulatory
network of stress-related miRNAs. However, such observations noted in this study suggest a
promising potential in the role of miRNAs with regards to regulatory mechanisms that govern
the response of RPE cells to chronic oxidative stress. This provides a new level of insight as well
as potential target molecules of interest in studies involving the progression of AMD.
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